DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Kronox Lab Sciences Publishes Q1 FY2026 Unaudited Results in Newspapers

TipRanks 7 hrs ago·16 Aug 2026, 11:56 am

Kronox LAB Sciences

Kronox Lab Sciences has released its unaudited Q1 FY2026 results in newspapers. This move is part of the company's regulatory compliance, keeping stakeholders informed about its financial performance. The publication of these results is significant for investors as it provides them with the latest financial insights into the company's operations. This information can help investors make more informed decisions about their investments in Kronox Lab Sciences. Investors should watch for further announcements or filings from the company, such as the audited results or management discussions, to get a more comprehensive understanding of the company's financial health and future prospects.